gaining a foothold in rapidly growing markets for kidney disease and iron deficiency treatments that complement its core immunodeficiency and haemophilia therapies.
Proxy votes on the $12 billion spin-off decision flooded in – and the retail giant’s shareholders gave the deal a resounding “yes”.Transurban Group extended its dominance over Australia’s tollroads by taking full control of Sydney motorways company WestConnex.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: